Farmacosmo S.p.A. (BIT:COSMO) signed a binding agreement for the acquisition of 69.88% stake in VIN.CI. SRL from Vincenzo Cioffi on August 9, 2022. In addition, the assembly of the members of Vin.Ci. who, following the resignation of the previous sole director, appointed a board of directors chaired by Roberto Frullone, director of general affairs of Farmacosmo, flanked by Fabio de Concilio, managing director of Farmacosmo, and Paolo Cimmino, CFO and investor relations manager of Pharmacosm.